The marketing study of the pharmaceutical market of Ukraine in the segment of antihemorrhagic agents to stop dental bleeding




Ukrainian pharmaceutical market; dental bleeding; antihemorrhagic agents; marketing research.


Aim. To conduct the marketing research of the Ukrainian market in the segment of antihemorrhagic agents used in dentistry.
Materials and methods. The study was performed using the structural analysis, logical and graphical methods, marketing analysis methods.
Results. The state of the Ukrainian market of drugs of this group has been determined. The market structure has been revealed in the number of names, brands, in forms of production, manufacturers, composition. Despite the sufficient number of registered drugs at the market (26 positions), a rather small arsenal  of active substances (4) and dosage forms (3) can be observed. The market is characterized by a limited amount of drugs with a certain pharmacodynamics combining a rapid hemostatic effect, safety in use, the ability to suppress bacterial flora, and without the effect on healthy tissues. However, a positive moment should be noted: by the structure of manufacturer countries the market remains domestic (60 : 40).
Conclusions. The Ukrainian pharmaceutical market is characterized by a sufficient assortment of hemostatic agents, but the use of these drugs in dentistry has its limitations. Dental doctors have certain problems with the occurrence of capillary bleeding and require a sufficient amount of effective and fastacting drugs for local application. Therefore, the search and creation of new drugs with a similar action at this stage remains a relevant scientific issue.

Author Biographies

I. S. Laba, National University of Pharmacy

Postgraduate student of the Department of Biotechnology

Yu. M. Azarenko, National University of Pharmacy

Candidate of Pharmacy (Ph.D.), associate professor of the Department of Biotechnology

O. М. Ievtushenko, National University of Pharmacy

Doctor of Pharmacy (Dr. habil.), professor of the Department of Pharmaceutical Management and Marketing


Копейкин В. Н. Ортопедическое лечение заболеваний пародонта. Москва : Триада-Х, 1998. 175 с.

Стародубова О. А., Золочівська З. В. Методи гемостазу в ротовій порожнині. Медицина транспорту України. 2005. № 1. С. 86–88.

Гемостатические препараты, применяемые в оториноларингологии : учеб.-метод. пособие / Ю. Е. Еременко. Минск : БГМУ, 2009. 19 с.

Профилактика кровотечения при операции удаления зуба у пациентов, находящихся на антикоагулянтной терапии / А. В. Павленко и др. Современная стоматология. 2014. № 1. С. 116–120.

Aframian D. J., Lalla R. V., Peterson D. E. Management of dental patients taking common hemostasisaltering medications. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology. 2007. Vol. 103. P45.E1–S45.E11. DOI:

Тагиева Ф. Р. Гемостатические средства местного действия в стоматологической практике. Здравоохранение. 2015. № 1. С. 27–32.

Гриновець І. С. Розробка складу, технології і дослідження стоматологічних лікарських плівок : автореф. дис. … канд. фарм. наук : 15.00.01 / Львів. нац. мед. ун–т ім. Д. Галицького. Львів, 2013. 24 c.

Halpern L. R., Adams D. R., Clarkson E. Treatment of the dental patient with bleeding dyscrasias: etiologies and management options for surgical success in practice. Dental Clinics of North America. 2020. Vol. 64, Iss. 2. P. 411–434. DOI:

Sandhu S., Sankar V., Villa А. Bleeding risk in thrombocytopenic patients after dental extractions: a retrospective single-center study. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2020. Vol. 129, Iss. 5. P. 478–483. DOI:

AlSheef М., Gray J., AlShammari A. Risk of postoperative bleeding following dental extractions in patients on antithrombotic treatment. The Saudi Dental Journal. 2020. DOI:

Bleeding frequency of patients taking ticagrelor, aspirin, clopidogrel, and dual antiplatelet therapy after tooth extraction and minor oral surgery / O. Doganay et al. The Journal of the American Dental Association. 2018. Vol. 149, Iss. 2. P. 132–138. DOI:

Postoperative bleeding associated with antiplatelet and anticoagulant drugs: A retrospective study / R. T. Rubino et al. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2019. Vol. 128, Iss. 3. P. 243–249. DOI:

Suzen M., Develi T., Uckan S. Prevalence of postoperative secondary bleeding and its relationship with intraoperative massive bleeding in patients undergoing orthognathic surgery. Journal of Stomatology, Oral and Maxillofacial Surgery. 2020. Vol. 122, Iss. 1. P. 29–32. DOI:

Bleeding assessment in oral surgery: A cohort study comparing individuals on anticoagulant therapy and a non-anticoagulated group / A. L. Rocha et al. Journal of Cranio-Maxillofacial Surgery. 2019. Vol. 47, Iss. 5. P. 798–804. DOI:

Incidence of bleeding after minor oral surgery in patients on dual antiplatelet therapy: a systematic review and meta-analysis / A. Ockerman et al. International Journal of Oral and Maxillofacial Surgery. 2020. Vol. 49, Iss. 1. P. 90–98. DOI:

Невідкладні стани в стоматологічній практиці : навч. посіб. / І. М. Скрипник та ін. 2-е вид., випр. Київ : Медицина, 2017. 224 с.

Current herbal medicine as an alternative treatment in dentistry: In vitro, in vivo and clinical studies / E. T. Moghadam et al. European Journal of Pharmacology. 2020. Vol. 889. P. 173665. DOI:

Динаміка розвитку ринку стоматологічних лікарських засобів України / Л. Л. Давтян та ін. Фармацевтичний журнал. 2015. № 6. С. 10–18.

Державний реєстр лікарських засобів України. URL:

Компендиум: лекарственные препараты. URL:

Мазур И. П., Ставская Д. М., Гелашвили Л. Т. Применение фармацевтических препаратов в стоматологии. Современная стоматология. 2016. № 2. С. 24–27





Social marketing and pharmacoeconomic research